Rheumatology Investigations and Management Flashcards
What is the criteria for diagnosing RA?
ACR/EULAR classification criteria
RA investigations
Blood testing (anaemia, raised platelets)
Inflammatory markers
Autoantibodies (anti-CCP)
Imaging (x-ray, US, MRI)
RA management
DMARD (1st methotrexate, 2nd sulfasalazine, 3rd hydroxychloroquine)
Steroids (for exacerbations)
Biologics (if DAS28 greater than 5.1 on 2 occasions 4 weeks apart)
Lupus diagnostic investigations
ANA Anti-dsDNA Anti-Sm Antiphospholipid ab Low complement Direct coombs test (haemolytic anaemia)
Lupus organ involvement investigations (depend on symptoms)
CXR Pulmonary function tests CT chest Urine protein quantification Renal biopsy Echocardiogram Nerve conduction studies MRI brain
SLE management
NSAIDs and simple analgesia
Hydroxychloroquine (may reduce systemic complications)
Steroids (varying dose for complications)
DMARDs
Biologics
Raynauds management
Calcium channel blockers or PDE5 inhibitors (sildefanil)
If digital ulcers - prostacyclin analogues (iloprost), botox injections, endothelin receptor antagonists (bosentan)
Systemic sclerosis management
Yearly ECHO and PFTs
Treat raynauds
Treat reflux (PPI)
Treat pulmonary fibrosis (immunosuppression)
Treat pulmonary hypertension (prostacyclin analogues, endothelin receptor antigonists, PDE5 inhibitors)
Tight blood pressure control (ACEI)
Sjogrens investigations
Antibodies (anti-ro and anti-la, ANA) Salivary gland ultrasound and biopsy (if antibodies negative) Inflammatory markers (high ESR/PV) Raised IgG Cytopaenia
Sjogrens management
Lubricants
Strong fluoride toothpaste
Hydroxychloroquine (if fatigue and arthralgia)
Immunosuppression for major organ involvement
Antiphospholipid investigations
Autoantibodies (anti-cardiolipin, lupus anticoagulant, beta 2 glycoprotein)
Thrombocytopenia
Anti-phospholipid management
Lifelong anti-coagulation IF THROMBOSIS
General principles of CTD management
Assess disease severity
Urinalysis
CXR, PFT, ECHO
Manage cardiovascular risk factors
If major organ involvement - immunosuppression
If not - hydroxychloroquine, symptomatic management
Poly/dermatomyositis investigations
Blood tests (CK, inflammatory markers, U&E, PTH, TSH) Autoantibodies (ANA, anti-Jo-1) Electromyography Muscle biopsy (definitive test) MRI
Poly/dermatomyositis management
Steroids (prednisolone)
Immunosuppressants (steroid sparing)